Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment

Z H Wang1, D Yu, H K Li

  • 1Department of Anatomy, Chinese University of Hong Kong, China.

Anticancer Research
|April 13, 2001
PubMed

Insights

Arsenic trioxide (As2O3) alters nuclear matrix proteins in mouse neuroblastoma cells, indicating early apoptosis. Increased Hsc expression serves as a sensitive marker for detecting this cellular change.

Area of Science:

  • Cell Biology
  • Toxicology
  • Cancer Research

Background:

  • Arsenic trioxide (As2O3) is known to induce apoptosis in cancer cells.
  • Nuclear matrix proteins play crucial roles in cellular processes, including apoptosis.
  • Neuroblastoma cells are a model for studying neuronal development and cancer.

Purpose of the Study:

  • To investigate the effects of arsenic trioxide on nuclear matrix protein profiles in mouse neuroblastoma cells.
  • To identify potential biomarkers for early apoptosis detection.

Main Methods:

  • Treatment of Neuro-2a cells with 2 microM arsenic trioxide.
  • Analysis of nuclear matrix protein alterations using TUNEL assay.
  • Assessment of apoptosis through DNA laddering.

Main Results:

  • Arsenic trioxide significantly inhibited the growth of Neuro-2a cells.
  • Alterations in nuclear matrix proteins and apoptosis were observed as early as 24 hours post-treatment.
  • Increased expression of Hsc (Heat shock cognate protein) was noted in the nuclear matrix proteins of treated cells.

Conclusions:

  • The composition of nuclear matrix proteins changes before significant apoptosis occurs.
  • Increased expression of Hsc in nuclear matrix proteins can be a sensitive indicator for early apoptosis detection in neuroblastoma cells.